Squarepoint Ops LLC

Position in GLUE — Monte Rosa Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in GLUE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,007,462

+$1,397,052 QoQ

Shares Held

82,953

+123.6% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 193 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. GLUE ranks #76 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,007,462	82,953	+123.6%	Shares	Defined	2026-08-14
2026-03-31	$610,410	37,107	+270.0%	Shares	Defined	2026-05-15
2025-12-31	$157,254	10,029	-89.4%	Shares	Defined	2026-02-13
2025-09-30	$701,778	94,707	-46.8%	Shares	Defined	2025-11-14
2025-06-30	$803,393	178,136	+462.8%	Shares	Defined	2025-08-27
2024-12-31	$219,678	31,654	+39.7%	Shares	Defined	2025-02-14
2024-06-30	$84,767	22,665	+29.8%	Shares	Defined	2024-08-14
2023-12-31	$98,660	17,462	+24.7%	Shares	Defined	2024-02-14
2023-03-31	$109,044	13,998	-50.7%	Shares	Defined	2023-05-15
2022-09-30	$232,109	28,410	+85.7%	Shares	Defined	2022-11-14
2022-06-30	$147,970	15,302	-45.8%	Shares	Defined	2022-08-15
2021-06-30	$640,344	28,209	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.